Patient-derived breast tumor xenografts facilitating personalized cancer therapy
暂无分享,去创建一个
Jenny C. Chang | J. Pietenpol | B. Lehmann | M. Landis | Jennifer A Pietenpol | Jenny C Chang | Brian D Lehmann | Melissa D Landis
[1] B. Vonderhaar,et al. Local regulation of human breast xenograft models , 2010, Journal of cellular physiology.
[2] C. Perou,et al. PAM 50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer , 2012 .
[3] X. Chen,et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.
[4] I. Cuthill,et al. Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .
[5] E. Repasky,et al. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. , 1996, The cancer journal from Scientific American.
[6] Jason I. Herschkowitz,et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.
[7] T. Sørlie,et al. Molecular profiling and characterization of luminal‐like and basal‐like in vivo breast cancer xenograft models , 2009, Molecular oncology.
[8] Tzong-Shiue Yu,et al. A restricted cell population propagates glioblastoma growth after chemotherapy , 2012 .
[9] C. Fan,et al. PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer , 2012, Breast Cancer Research and Treatment.
[10] Mark T. W. Ebbert,et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes , 2011, Nature Medicine.
[11] J. Harrell,et al. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures , 2012, Breast Cancer Research and Treatment.
[12] Hans Clevers,et al. Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas , 2012, Science.
[13] Michael F Clarke,et al. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. , 2009, Cell stem cell.
[14] A. Vincent-Salomon,et al. Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts , 2012, Breast Cancer Research and Treatment.
[15] D. Birnbaum,et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. , 2010, The Journal of clinical investigation.
[16] Xi Chen,et al. TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer , 2012, Cancer informatics.
[17] S. Hilsenbeck,et al. Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model , 2012, PloS one.
[18] Nicholas J. Wang,et al. Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors , 2012, Breast Cancer Research and Treatment.
[19] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[20] A. Freitas,et al. Humanized mice: current states and perspectives. , 2012, Immunology letters.
[21] H. Kleinman,et al. Basement membrane and the SIKVAV laminin-derived peptide promote tumor growth and metastases , 1991, Cancer and Metastasis Reviews.
[22] A. Vincent-Salomon,et al. A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays , 2007, Clinical Cancer Research.
[23] H. Fiebig,et al. Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenografts. , 1990, European journal of cancer.
[24] G. Mills,et al. P5-21-01: A Renewable Tissue Resource of Phenotypically Stable Human Breast Cancer Xenografts for Preclinical Studies. , 2011 .
[25] H. Bush,et al. Breast Cancer Research , 1978, British Journal of Cancer.
[26] A. Maier,et al. Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery. , 2004, European journal of cancer.
[27] W. Hait,et al. Anticancer drug development: the grand challenges , 2010, Nature Reviews Drug Discovery.
[28] M. Ellis,et al. Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. , 2012, The Journal of clinical investigation.
[29] R. Weinberg,et al. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. , 2007, Cancer research.
[30] Anne Vincent-Salomon,et al. Molecular profiling of patient-derived breast cancer xenografts , 2012, Breast Cancer Research.
[31] A. Cesano,et al. Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice. , 1998, The American journal of pathology.
[32] Vandana Iyer,et al. Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes. , 2012, Cancer research.
[33] R. Custer,et al. Growth of human normal and neoplastic mammary tissues in the cleared mammary fat pad of the nude mouse. , 1975, Journal of the National Cancer Institute.
[34] Jennifer A. Prescher,et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models , 2010, Proceedings of the National Academy of Sciences.
[35] G. Page,et al. Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture , 2004, Breast Cancer Research.
[36] D. Decaudin. Primary human tumor xenografted models (‘tumorgrafts’) for good management of patients with cancer , 2011, Anti-cancer drugs.
[37] L. Seymour,et al. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[38] Zhiyuan Hu,et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors , 2007, Genome Biology.
[39] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Weinberg,et al. Reconstruction of functionally normal and malignant human breast tissues in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[41] Jason I. Herschkowitz,et al. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells , 2011, Proceedings of the National Academy of Sciences.
[42] L. Coussens,et al. Leukocytes in mammary development and cancer. , 2011, Cold Spring Harbor perspectives in biology.
[43] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[44] O. Fodstad,et al. Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. , 1992, Cancer research.
[45] R. DePinho,et al. Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in mice , 2009, Proceedings of the National Academy of Sciences.
[46] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[47] M. Ellis,et al. Erratum: Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models (Journal of Clinical Investigation (2012) 122, 4 (1541-1552) DOI: 10.1172/JCI58765) , 2012 .
[48] Joshua F. McMichael,et al. Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.
[49] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] Piyush B. Gupta,et al. Contributions of estrogen to ER-negative breast tumor growth , 2006, The Journal of Steroid Biochemistry and Molecular Biology.
[51] A. Lux,et al. Of Mice and Men: The Need for Humanized Mouse Models to Study Human IgG Activity in Vivo , 2012, Journal of Clinical Immunology.
[52] Benjamin D. Simons,et al. Defining the mode of tumour growth by clonal analysis , 2012, Nature.
[53] G. Bastert,et al. Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice , 2003, International journal of cancer.
[54] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[55] R. Clarke. The role of preclinical animal models in breast cancer drug development , 2009, Breast Cancer Research.
[56] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[57] F. Miller,et al. Interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophosphamide and methotrexate. , 1981, Cancer research.